Products
Our Products
HLS is focused on treatment products for the central nervous system (CNS), and cardiovascular specialties.
Product Pipeline |
||||
|---|---|---|---|---|
| CARDIOVASCULAR (CV) | ||||
| Vascepa | CV risk reduction | Canada | Marketed | |
| Trinomia | CV risk reduction | Canada | Under review | |
| CENTRAL NERVOUS SYSTEM (CNS) | ||||
| Clozaril | Schizophrenia | U.S./Canada | Marketed | |
| CSAN Pronto | WBC Point-of-Care Diagnostic | Canada | Marketed | |
| PERSERIS | Schizophrenia | Canada | Approved and in pre-launch phase | |
| MyCare Psychiatry | Psychiatric Therapeutic Drug Monitoring | Canada | Marketed | |
| ROYALTY PRODUCTS | ||||
| Royalty Portfolio | Multiple Indications | Global | Marketed by third parties | |
For U.S. Residents, click here for commercial product information.
For Canadian Residents, please click on the Canadian flag above for more commercial product information.